← Leaderboards
Tatiana V Byzova
Cleveland Clinic Foundation
$20,821,892
Attributed
$21,597,064
Total exposure
10
Grants
10
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2005–25$2.5M$1.9M$1.3M$625K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$21,597,064 · 10
By mechanism
R01$16,527,185 · 6
P01$5,049,929 · 3
R13$19,950 · 1
Top collaborators
- Eugene A Podrez2 shared
Most similar at Cleveland Clinic Foundation
Same institution · by research overlap
- Jun Qin$25,653,832
- Xiaoxia Li$26,894,441
Others in their field
Top investigators on “In Vivo”
- David Heimbrook · Leidos Biomedical Research, Inc.$371,850,582
- Leonard Freedman · Leidos Biomedical Research, Inc.$304,459,298
- Dennis R. Burton · Scripps Research Institute$212,708,174
- Mark S Klempner · Tufts Medical Center$128,021,180
- Florian Krammer · Icahn School Of Medicine At Mount Sinai$104,723,856
- David M. Margolis · University Of Texas Sw Med Ctr/Dallas$98,374,200
Research focus
In VivoIntegrinsMolecularResponseMediatingRegulationCellsAngiogenesisMigrationComplexBiologyBlood VesselsTissuesEndothelial CellsTumorIn VitroVascular Endothelial Growth FactorsEndotheliumSignal TransductionMalignant NeoplasmsPathologyGrowthPlayLigands
Grant awards (52)
Novel oxidative pathway targets microglia in Alzheimer's disease$767,342
R01 · FY2025 · AG · contact PI
Novel oxidative pathway targets microglia in Alzheimer's disease$783,003
R01 · FY2024 · AG · contact PI
Role of TLR2 in angiogenesis$641,356
R01 · FY2022 · HL · contact PI
Platelets in Cancer$663,334
R01 · FY2021 · HL · contact PI
Role of TLR2 in angiogenesis$641,356
R01 · FY2021 · HL · contact PI
Novel role of integrins in paracrine regulation of vasculature$617,218
R01 · FY2021 · HL · contact PI
Platelets in Cancer$663,334
R01 · FY2020 · HL · contact PI
Role of TLR2 in angiogenesis$639,696
R01 · FY2020 · HL · contact PI
Novel role of integrins in paracrine regulation of vasculature$617,218
R01 · FY2020 · HL · contact PI
Platelets in Cancer$659,214
R01 · FY2019 · HL · contact PI
Role of TLR2 in angiogenesis$655,373
R01 · FY2019 · HL · contact PI
Novel role of integrins in paracrine regulation of vasculature$613,384
R01 · FY2019 · HL · contact PI
Project 3 Function of Kindlin-3 in blood and endothelial cells$367,621
P01 · FY2019 · HL · contact PI
Platelets in Cancer$659,214
R01 · FY2018 · HL · contact PI
Novel role of integrins in paracrine regulation of vasculature$623,384
R01 · FY2018 · HL · contact PI
Project 3 Function of Kindlin-3 in blood and endothelial cells$360,268
P01 · FY2018 · HL · contact PI
Gordon Research Conference on Vascular Cell Biology$19,950
R13 · FY2018 · HL · contact PI
Regulation of Akt-integrin pathway in endothelial function and neovasculature$396,250
R01 · FY2017 · HL · contact PI
Project 3 Function of Kindlin-3 in blood and endothelial cells$367,620
P01 · FY2017 · HL · contact PI
Regulation of Akt-integrin pathway in endothelial function and neovasculature$396,250
R01 · FY2016 · HL · contact PI
Project 3 Function of Kindlin-3 in blood and endothelial cells$367,620
P01 · FY2016 · HL · contact PI
Regulation of Akt-integrin pathway in endothelial function and neovasculature$390,306
R01 · FY2015 · HL · contact PI
Project 3 Function of Kindlin-3 in blood and endothelial cells$367,621
P01 · FY2015 · HL · contact PI
Regulation of Akt-integrin pathway in endothelial function and neovasculature$396,250
R01 · FY2014 · HL · contact PI
AlphaVbetaIII Activation in Blood and Endothelial Cells in Angiogenesis$311,574
P01 · FY2013 · HL · contact PI
Regulation of Integrins in Neovasculature Development$388,575
R01 · FY2012 · HL · contact PI
AlphaVbetaIII Activation in Blood and Endothelial Cells in Angiogenesis$327,283
P01 · FY2012 · HL · contact PI
Regulation of Integrins in Neovasculature Development$392,500
R01 · FY2011 · HL · contact PI
AlphaVbetaIII Activation in Blood and Endothelial Cells in Angiogenesis$327,283
P01 · FY2011 · HL · contact PI
Role of Integrins and bone matrix in prostate cancer$281,501
R01 · FY2011 · CA · contact PI
Regulation of Integrins in Neovasculature Development$392,500
R01 · FY2010 · HL · contact PI
AlphaVbetaIII Activation in Blood and Endothelial Cells in Angiogenesis$327,283
P01 · FY2010 · HL · contact PI
Role of Integrins and bone matrix in prostate cancer$290,207
R01 · FY2010 · CA · contact PI
Regulation of Integrins in Neovasculature Development$392,500
R01 · FY2009 · HL · contact PI
AlphaVbetaIII Activation in Blood and Endothelial Cells in Angiogenesis$350,406
P01 · FY2009 · HL · contact PI
Role of Integrins and bone matrix in prostate cancer$281,757
R01 · FY2009 · CA · contact PI
aVB3 Activation and Phosphorylation in Angiogenesis$330,964
P01 · FY2008 · HL · contact PI
Role of Integrins and bone matrix in prostate cancer$273,550
R01 · FY2008 · CA · contact PI
aVB3 Activation and Phosphorylation in Angiogenesis$327,928
P01 · FY2007 · HL · contact PI
Activation of alpha5beta3 integrin on blood and endothelial cells$326,412
R01 · FY2007 · HL · contact PI
Role of Integrins and bone matrix in prostate cancer$270,840
R01 · FY2007 · CA · contact PI
Activation of blood and endothelial cell a5b3 integrin$336,161
R01 · FY2006 · HL · contact PI
aVB3 Activation and Phosphorylation in Angiogenesis$314,559
P01 · FY2006 · HL · contact PI
Integrins and bone matrix in prostate cancer$262,952
R01 · FY2006 · DK · contact PI
Activation of blood and endothelial cell a5b3 integrin$344,250
R01 · FY2005 · HL
aVB3 Activation and Phosphorylation in Angiogenesis$305,397
P01 · FY2005 · HL
Integrins and bone matrix in prostate cancer$269,280
R01 · FY2005 · DK
Activation of blood and endothelial cell a5b3 integrin$344,250
R01 · FY2004 · HL
aVB3 Activation and Phosphorylation in Angiogenesis$296,502
P01 · FY2004 · HL
Integrins and bone matrix in prostate cancer$269,280
R01 · FY2004 · DK
Activation of integrin on blood &endothelial cells$329,174
R01 · FY2003 · HL
Integrins and bone matrix in prostate cancer$258,014
R01 · FY2003 · DK